Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Development of candidate vaccine strategies against Rift Valley fever virus

Bhardwaj, Nitin (2011) Development of candidate vaccine strategies against Rift Valley fever virus. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (3MB) | Preview


Rift Valley Fever virus (RVFV) is an arthropod-borne bunyavirus that causes a zoonotic disease associated with abortion storms, neonatal mortality in livestock and hemorrhagic fever with a high case/fatality ratio in humans. To date, vaccine developments against RVF have been based on inactivated or attenuated strains but their widespread use has been hampered due to deleterious effects or incomplete protection, justifying further studies to improve the existing vaccines or to develop others. To address this, DNA plasmid and alphavirus replicon vector (VEEV) expressing RVFV Gn glycoprotein were constructed and evaluated for their ability to induce protective immune responses in mice against RVFV. An experimental live-attenuated vaccine (MP12) and its inactivated counterpart (WIV MP12) were developed to serve as benchmarks for comparison. Test vaccine candidates efficiently expressed the RVFV glycoprotein in vitro and elicited anti-RVFV antibody responses in immunized mice, as determined by RVFV specific ELISA, IgG isotype ELISA, and virus neutralization. Interestingly, these vaccine strategies elicited cellular immune responses as determined by Gn specific ELISPOT. More importantly these vaccines not only protected immunized mice from virulent RVFV when challenged via intraperitoneal route, but also conferred protection when challenged via aerosol route. This work is of public health significance as it describes the development of safe and effective vaccine candidates that have the ability to protect both livestock and humans against possible routes of exposure to this zoonotic threat.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairRoss, Ted M.tmr15@pitt.eduTMR15
Committee MemberKinchington, Paul R.kinchingtonp@upmc.eduKINCH
Committee MemberReinhart, Todd A.reinhar@pitt.eduREINHAR
Committee MemberAyyavoo, Velpandivelpandi@pitt.eduVELPANDI
Date: 29 June 2011
Date Type: Completion
Defense Date: 26 January 2011
Approval Date: 29 June 2011
Submission Date: 2 March 2011
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Institution: University of Pittsburgh
Schools and Programs: School of Public Health > Infectious Diseases and Microbiology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Bunyavirus; DNA; Replicon
Other ID:, etd-03022011-144241
Date Deposited: 10 Nov 2011 19:31
Last Modified: 19 Dec 2016 14:35


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item